Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Phase 2 Terminated 23 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test if denufosol will remove the fluid build-up in the eye so that the retina can be re-attached without invasive surgery.

Timeline

Start: 2004-06
Primary completion: 2006-04
Completion: 2006-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	denufosol	Other / unclassified	—	Intravitreal

Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment

Summary

Timeline

Drugs

Indications